To view this article, please confirm that you are a healthcare professional by clicking 'Confirm' below.
Glycaemic control and weight reduction in type 2 diabetes with weekly tirzepatide, a novel GIP/GLP-1 agonist
Results from the SURPASS-2 trial
Back